Neumora's schizophrenia drug faces FDA hold over convulsions in rabbits

The FDA has placed a phase 1 trial of Neumora Therapeutics’ schizophrenia therapy on hold after preclinical data revealed rabbits dosed with the drug had experienced convulsions.